These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2371491)

  • 1. Acetylsalicylic acid inhibits platelet PAI-1 antigen release without affecting circulating PAI-1 antigen in plasma.
    Cogo A; Ling E; Sturk A; ten Cate JW; Prandoni P
    Ric Clin Lab; 1990; 20(2):113-7. PubMed ID: 2371491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease.
    Simpson AJ; Booth NA; Moore NR; Bennett B
    Br J Haematol; 1990 Aug; 75(4):543-8. PubMed ID: 2207005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen levels of plasminogen activator inhibitor type 1 in citrated plasma: determination of the contribution of platelets.
    Grimaudo V; Bachmann F; Kruithof EK
    Haemostasis; 1990; 20(6):329-33. PubMed ID: 2151572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of single oral dose of aspirin on human platelet functions and plasma plasminogen activator inhibitor-1.
    Mousa SA; Forsythe MS; Bozarth JM; Reilly TM
    Cardiology; 1993; 83(5-6):367-73. PubMed ID: 8111770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms contributing to increased synthesis of plasminogen activator inhibitor type 1 in endothelial cells by constituents of platelets and their implications for thrombolysis.
    Fujii S; Hopkins WE; Sobel BE
    Circulation; 1991 Feb; 83(2):645-51. PubMed ID: 1991382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor (PAI-1) in plasma and platelets.
    Booth NA; Simpson AJ; Croll A; Bennett B; MacGregor IR
    Br J Haematol; 1988 Nov; 70(3):327-33. PubMed ID: 3264718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin effect on the release of plasminogen activator inhibitors by human platelets.
    Woods AI; Lazzari MA
    Thromb Res; 1988 Oct; 52(2):119-25. PubMed ID: 3143164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of nitric oxide donors on the release of plasminogen activator inhibitor (PAI) from rabbit platelets in vitro.
    Korbut R; Marcinkiewicz E; Cieślik K; Gryglewski RJ
    J Physiol Pharmacol; 1995 Mar; 46(1):37-44. PubMed ID: 7599336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of plasminogen activator inhibitor by products released from platelets.
    Fujii S; Sobel BE
    Circulation; 1990 Oct; 82(4):1485-93. PubMed ID: 2401077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on fibrinolysis and platelet function].
    Deguchi K; Murashima S; Nishikawa M; Shirakawa S
    Nihon Rinsho; 1992 Feb; 50(2):297-302. PubMed ID: 1613983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.
    Declerck PJ; Alessi MC; Verstreken M; Kruithof EK; Juhan-Vague I; Collen D
    Blood; 1988 Jan; 71(1):220-5. PubMed ID: 3257145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1.
    Preissner KT; Holzhüter S; Justus C; Müller-Berghaus G
    Blood; 1989 Nov; 74(6):1989-96. PubMed ID: 2478218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet hyporesponsiveness to acetylsalicylic acid can be transferred by plasma in humans.
    Anger K; Kempfert J; Kostelka M; Mohr FW; Dhein S
    Pharmacology; 2010; 85(4):241-7. PubMed ID: 20332671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.
    Derhaschnig U; Schweeger-Exeli I; Marsik C; Cardona F; Minuz P; Jilma B
    Platelets; 2010; 21(5):320-8. PubMed ID: 20608787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM; Böger RH; Schubert M; Frölich JC
    Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
    Leiper K; Croll A; Booth NA; Moore NR; Sinclair T; Bennett B
    J Clin Pathol; 1994 Mar; 47(3):214-7. PubMed ID: 8163691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.
    Müller TH; Su CA; Weisenberger H; Brickl R; Nehmiz G; Eisert WG
    Br J Clin Pharmacol; 1990 Aug; 30(2):179-86. PubMed ID: 2206782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR; Sobel BE
    Thromb Res; 1993 Dec; 72(5):413-21. PubMed ID: 8303684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.